Mark E. Sutter, M.D.
Clinical Interests
Dr. Sutter's clinical interest focuses on poisonings and overdoses particularly in critically ill
patients. Dr. Sutter is interested in pesticide toxicity and cardiovascular medication toxicity.
Title
Associate Professor
Toxicology Fellowship Director
Specialty
Emergency Medicine
Department
Emergency Medicine
Division
Emergency Medicine
Address/Phone
UC Davis Medical Center, Emergency Medicine Department, 2315 Stockton Blvd. Sacramento, CA
95817
Phone: 916-734-3790
Additional Phone
Education
Physician Referrals: 800-4-UCDAVIS (800-482-3284)
M.D., University of Vermont College of Medicine, Burlington, Vermont, 2002
B.S., UCLA, Los Angeles, California, 1997
Internships
University of California, Davis, Sacramento, CA, 2006
Residency
University of California, Davis, Sacramento, CA, 2005
Fellowships
Emory-Centers for Disease Control, Atlanta, GA, 2008
Board Certifications
American Board of Emergency Medicine, 2006
American Board of Medical Toxicology, 2008
Professional Memberships
American Association of Clinical Toxicology
American Association of Medical Toxicology
American College of Emergency Physicians
Society of Academic Emergency Medicine
Select Recent Publications
Sutter ME, Turnipseed S, Samuel P, White R. The use of ultrasound for lower extremity venous
thrombosis: The incidence of alternative findings. Manuscript accepted by Journal of Emergency
Medicine. Abstract published and presented at the Society for Academic Emergency Medicine
Conference, New York City, May 2005.
Mark E. Sutter, M.D.
Sutter ME, Diercks D. Management of acute decompensated heart failure. Clinical Bulletin, Sterling
Healthcare, March 2005, Limited distribution for CME accreditation.
Sutter ME, Diercks D. New insights into decompensated heart failure. Emergency Medicine, 2005;
37 (6): 18-25.
Sutter ME, Diercks D. Review of JAMA article. Does this patient have a torn meniscus or ligament
of the knee? Value of the physical examination. Lifeline. March 2004; 24. Original article, JAMA,
2001; 286: 1610-1620.
Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Defining the ideal cutpoint for determining PSA
recurrence after radical prostatectomy. Urology, 2003; 61(2); 365-369.
Freeland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Race is not an independent predictor of
biochemical recurrence after radical prostatectomy in an equal access medical center. Urology.
2000; 56(1): 87-91.
Freeland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ. Clinical characteristics in black
and white men with prostate cancer in an equal access medical center. Urology. 2000; 55(3): 387390.
© 2016 UC Regents